Pharmaceutical

Cotinga Pharmaceuticals (TSXV:COT) has announced its financial and operating results for Q4 and full year ended April 30, 2018. As quoted in the press release: Advanced the clinical development of COTI-2: In March 2018, Cotinga submitted an updated clinical package to regulatory authorities to expand its ongoing clinical trial of COTI-2. The protocol amendment expanded …

Cotinga Pharmaceuticals (TSXV:COT) has announced its financial and operating results for Q4 and full year ended April 30, 2018.

As quoted in the press release:

Advanced the clinical development of COTI-2:

  • In March 2018, Cotinga submitted an updated clinical package to regulatory authorities to expand its ongoing clinical trial of COTI-2. The protocol amendment expanded the clinical trial to evaluate COTI-2 as a combination therapy in a wide spectrum of cancers.
  • In April 2018, Cotinga and its collaborators from MD Anderson Cancer Center and Northwestern Medicine presented data on COTI-2 at the American Association for Cancer Research (AACR) Annual Meeting 2018 in Chicago, Illinois.
  • Subsequent to the reporting quarter, in May 2018, Cotinga announced the clearance of a protocol amendment for its ongoing clinical trial of COTI-2. The multi-part protocol amendment expanded the Phase 1b/2a trial to evaluate COTI-2 as a combination therapy in a wide spectrum of cancers.
  • Subsequent to the reporting quarter, in June 2018, Cotinga and its collaborators from MD Anderson Cancer Center presented data on COTI-2 at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.

Secured funding to support clinical development:

  • Subsequent to the reporting quarter, in May 2018, Cotinga closed a brokered and non-brokered private placement for total proceeds of approximately $2.010 million to support the continued clinical development of COTI-2. Roth Capital Partners, LLC acted as sole placement agent for the brokered offering in the United States.

Click here to read the full press release.

Featured

MARKETS

Markets
TSX20197.61+15.69
TSXV702.09-3.49
DOW31261.90+8.77
S&P 5003901.36+0.57
NASD11354.62-33.88
ASX7145.60+81.10

COMMODITIES

Commodities
Gold1846.53+0.13
Silver21.75+0.03
Copper4.30+0.02
Palladium1968.65+11.53
Platinum957.67+3.19
Oil110.35-1.86
Heating Oil3.62-0.05
Natural Gas8.06-0.25

DOWNLOAD FREE REPORTS

×